February 17th 2023
The launch of Amgen's adalimumab biosimilar Amjevita was just the start of a wave of biosimilars to treat autoimmune diseases.
February 15th 2023
January 30th 2023
February 14th 2022
Addressing Racial, Ethnic Disparities in RA and SLE Disease OutcomesNovember 9th 2021
A study presented at ACR Convergence 2021 examined the relationship between race/ethnicity, living in a disadvantaged neighborhood, and how often patients are prescribed disease-specific treatments.
Greater Satisfaction Reported With Extended-Wear Insulin Infusion Set for Type 1 DiabetesJune 25th 2021
A study presented during a poster session at the American Diabetes Association Virtual 81st Scientific Sessions evaluated performance, safety, and satisfaction of an extended-wear insulin infusion set in patients with type 1 diabetes.
High Adherence, Low Adverse Events Reported Across Different Oral Disease-Modifying TherapiesApril 21st 2021
Research presented at Academy of Managed Care Pharmacy’s 2021 virtual conference evaluated tolerance and adherence to oral disease-modifying therapies for relapsing-remitting multiple sclerosis.
Journal Club: Prefilled Pen to Deliver Methotrexate to Children With JIADecember 30th 2020
Prefilled syringes have been the way that many children with juvenile idiopathic arthritis get their methotrexate. A pilot study examines if prefilled pens might be a better option.